Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1933 1
1937 1
1945 2
1946 17
1947 19
1948 53
1949 47
1950 29
1951 63
1952 90
1953 86
1954 131
1955 135
1956 133
1957 216
1958 155
1959 193
1960 153
1961 192
1962 189
1963 193
1964 379
1965 286
1966 268
1967 426
1968 445
1969 548
1970 496
1971 578
1972 579
1973 570
1974 665
1975 754
1976 797
1977 1016
1978 962
1979 932
1980 1090
1981 1028
1982 1132
1983 1179
1984 1375
1985 1366
1986 1395
1987 1384
1988 1546
1989 1913
1990 2002
1991 1930
1992 2328
1993 2313
1994 2755
1995 2864
1996 3145
1997 3281
1998 3607
1999 3731
2000 4248
2001 4205
2002 4436
2003 4961
2004 5225
2005 5813
2006 6237
2007 6629
2008 7247
2009 7590
2010 8793
2011 9533
2012 10352
2013 10541
2014 11139
2015 11863
2016 12108
2017 12483
2018 13207
2019 13907
2020 15828
2021 16660
2022 16111
2023 15896
2024 15856
2025 830

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

276,361 results

Results by year

Filters applied: . Clear all
Page 1
Drug Combinations in Breast Cancer Therapy.
Fisusi FA, Akala EO. Fisusi FA, et al. Pharm Nanotechnol. 2019;7(1):3-23. doi: 10.2174/2211738507666190122111224. Pharm Nanotechnol. 2019. PMID: 30666921 Free PMC article. Review.
Breast cancer therapy involves a multidisciplinary approach comprising surgery, radiotherapy, neoadjuvant and adjuvant therapy. ...This review discusses therapeutic options for breast cancer treatments and various combinations that had be …
Breast cancer therapy involves a multidisciplinary approach comprising surgery, radiotherapy, neoadjuvant and adjuvant …
Adjuvant and neoadjuvant therapy for breast cancer.
Shien T, Iwata H. Shien T, et al. Jpn J Clin Oncol. 2020 Mar 9;50(3):225-229. doi: 10.1093/jjco/hyz213. Jpn J Clin Oncol. 2020. PMID: 32147701 Free article. Review.
Systemic therapies for operable breast cancer patients have improved outcomes and have thus become standard treatments. ...Neoadjuvant systemic therapy has a different aim. The efficacy of systemic therapies, based on the sensitivities to drugs, …
Systemic therapies for operable breast cancer patients have improved outcomes and have thus become standard treatments. …
Breast cancer.
Harbeck N, Gnant M. Harbeck N, et al. Lancet. 2017 Mar 18;389(10074):1134-1150. doi: 10.1016/S0140-6736(16)31891-8. Epub 2016 Nov 17. Lancet. 2017. PMID: 27865536 Review.
Breast cancer is one of the three most common cancers worldwide. Early breast cancer is considered potentially curable. ...In metastatic breast cancer, therapy goals are prolongation of survival and maintaining quality of life. ...
Breast cancer is one of the three most common cancers worldwide. Early breast cancer is considered potentially c …
Gene therapy: A promising approach for breast cancer treatment.
Dastjerd NT, Valibeik A, Rahimi Monfared S, Goodarzi G, Moradi Sarabi M, Hajabdollahi F, Maniati M, Amri J, Samavarchi Tehrani S. Dastjerd NT, et al. Cell Biochem Funct. 2022 Jan;40(1):28-48. doi: 10.1002/cbf.3676. Epub 2021 Dec 14. Cell Biochem Funct. 2022. PMID: 34904722 Review.
The study of the molecular basis of breast cancer has led to the introduction of gene therapy as an effective therapeutic approach for this cancer. ...In addition, clinical trial studies have shown that this approach is less toxic than traditional t …
The study of the molecular basis of breast cancer has led to the introduction of gene therapy as an effective therapeut …
Targeted therapy for breast cancer: An overview of drug classes and outcomes.
Jacobs AT, Martinez Castaneda-Cruz D, Rose MM, Connelly L. Jacobs AT, et al. Biochem Pharmacol. 2022 Oct;204:115209. doi: 10.1016/j.bcp.2022.115209. Epub 2022 Aug 14. Biochem Pharmacol. 2022. PMID: 35973582 Free article. Review.
Here we will review breast cancer targeted therapeutics in clinical use. We will provide the rationale for their indications and summarize clinical data in patients with different breast cancer subtypes, their impact on breast cancer …
Here we will review breast cancer targeted therapeutics in clinical use. We will provide the rationale for their indica …
Systemic Therapy in Breast Cancer.
Corti C, Batra-Sharma H, Kelsten M, Shatsky RA, Garrido-Castro AC, Gradishar WJ. Corti C, et al. Am Soc Clin Oncol Educ Book. 2024 Jun 1;44(3):e432442. doi: 10.1200/EDBK_432442. Am Soc Clin Oncol Educ Book. 2024. PMID: 39013124 Free article. Review.
Therapeutic advances in breast cancer have significantly improved outcomes in recent decades. In the early setting, there has been a gradual shift from adjuvant-only to neoadjuvant strategies, with a growing focus on customizing post-neoadjuvant treatments through e …
Therapeutic advances in breast cancer have significantly improved outcomes in recent decades. In the early setting, there has …
Clinical Diagnosis and Management of Breast Cancer.
McDonald ES, Clark AS, Tchou J, Zhang P, Freedman GM. McDonald ES, et al. J Nucl Med. 2016 Feb;57 Suppl 1:9S-16S. doi: 10.2967/jnumed.115.157834. J Nucl Med. 2016. PMID: 26834110 Free article. Review.
The diagnosis and management of breast cancer are undergoing a paradigm shift from a one-size-fits-all approach to an era of personalized medicine. ...This article reviews the diagnosis and treatment of breast cancer, including screening, staging, and …
The diagnosis and management of breast cancer are undergoing a paradigm shift from a one-size-fits-all approach to an era of p …
Hormone replacement therapy after breast cancer: Yes, No or maybe?
Ugras SK, Layeequr Rahman R. Ugras SK, et al. Mol Cell Endocrinol. 2021 Apr 5;525:111180. doi: 10.1016/j.mce.2021.111180. Epub 2021 Jan 26. Mol Cell Endocrinol. 2021. PMID: 33508379 Review.
Over nine million breast cancer survivors worldwide suffer compromised quality of life attributable to estrogen depletion related symptoms of menopause and side effects of cancer therapy. Hormone Replacement Therapy (HRT) is very effective in ma …
Over nine million breast cancer survivors worldwide suffer compromised quality of life attributable to estrogen depletion rela …
Advances in systemic therapies for triple negative breast cancer.
Leon-Ferre RA, Goetz MP. Leon-Ferre RA, et al. BMJ. 2023 May 30;381:e071674. doi: 10.1136/bmj-2022-071674. BMJ. 2023. PMID: 37253507 Review.
Triple negative breast cancer (TNBC) continues to be the subtype of breast cancer with the highest rates of recurrence and mortality. ...An improved understanding of tumor biology has resulted in the identification of subsets of patients with specific …
Triple negative breast cancer (TNBC) continues to be the subtype of breast cancer with the highest rates of recu …
The History of Early Breast Cancer Treatment.
Ben-Dror J, Shalamov M, Sonnenblick A. Ben-Dror J, et al. Genes (Basel). 2022 May 27;13(6):960. doi: 10.3390/genes13060960. Genes (Basel). 2022. PMID: 35741721 Free PMC article. Review.
"The story of cancer is the story of human ingenuity, resilience, and perseverance, but also of hubris, paternalism, and misperception" (Siddhartha Mukherjee). The present review discusses the evolution of early breast cancer (BC) treatment philosophy in the …
"The story of cancer is the story of human ingenuity, resilience, and perseverance, but also of hubris, paternalism, and misperceptio …
276,361 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "therapy breast cancer"